Tci Wealth Advisors, Inc. Xencor Inc Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$25.95 - $36.95 $6,098 - $8,683	235 Added 202.59%	351 $9,000
Q4 2022 Feb 06, 2023	BUY	$24.79 - $30.86 $2,850 - $3,548	115 Added 11500.0%	116 $3,000
Q3 2022 Nov 08, 2022	BUY	$24.62 - $32.44 $24 - $32	1 New	1 $0
Q1 2022 Apr 29, 2022	SELL	$26.68 - $41.63 $3,388 - $5,287	-127 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$30.65 - $35.68 $3,892 - $4,531	127 New	127 $4,000
Q2 2021 Aug 02, 2021	SELL	$34.33 - $44.68 $3,467 - $4,512	-101 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$40.81 - $53.88 $4,121 - $5,441	101 New	101 $4,000

214

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.09B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.